Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Express Scripts Holding Company (NASDAQ:ESRX), Lannett Company, Inc. (NYSEMKT: LCI), Aetna Inc (NYSE:AET), Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR)
Express Scripts Holding Company (NASDAQ:ESRX) managed to keep its gain at 1.46% on below -normal volume of 4.38M shares. The stock settled at $62.53 after floating in a range of $61.69 to $62.57. Its latest price has reached market capitalization of $50.18 billion. Its 52-week range has been $49.79 to $67.66. Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients.
For How Long ESRX will fight for Profitability? Read This Trend Analysis report
Lannett Company, Inc. (NYSEMKT: LCI) traded down on a volume of 4.31 million, higher than its standard daily volume. Shares have dropped-13.95% to $18.01. Over the last twelve months, the stock has gained 272.88% and faced a worst price of $3.93. Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company’s products manufactured and/or sold are prescription products.
Has LCI Found The Bottom And Ready To Gain Momentum? Find Out Here
Aetna Inc (NYSE:AET) settled 3.44% higher at $66.44 on above-normal volume of 4.25M shares during the last trading day. The stock has its 12-month high at $69.19 and 52-week low price was $40.32. It traded in a range of $64.24 to $66.50 during the last trading day. Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions.
Why Should Investors Buy AET After the Recent Fall? Just Go Here and Find Out
In the last trading session, Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was down on high volume, trading at a volume of 4.20M versus its average daily volume of 782,004.00 shares. At $12.59, the stock has attained market capitalization of 615.65 million. Optimer Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and Canada.
Why Should Investors Buy OPTR After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)